122 related articles for article (PubMed ID: 22883963)
1. PET-CT accurately predicts the pre-operative characteristics of colorectal hepatic metastases.
Jones C; Badger SA; McKie LD; Diamond T; Taylor MA; Lynch TB
Eur J Surg Oncol; 2012 Dec; 38(12):1184-8. PubMed ID: 22883963
[TBL] [Abstract][Full Text] [Related]
2. PET-CT as a predictor of outcome in resectable colorectal liver metastases.
Jones C; Badger SA; Stevenson M; Diamond T; McKie LD; Taylor MA; Wilson RH; Lynch TB
Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):466-72. PubMed ID: 24445726
[TBL] [Abstract][Full Text] [Related]
3. FDG-PET for the pre-operative evaluation of colorectal liver metastases.
Arulampalam TH; Francis DL; Visvikis D; Taylor I; Ell PJ
Eur J Surg Oncol; 2004 Apr; 30(3):286-91. PubMed ID: 15028310
[TBL] [Abstract][Full Text] [Related]
4. Role of FDG-PET staging in selecting the optimum patient for hepatic resection of metastatic colorectal cancer.
Strasberg SM; Dehdashti F
J Surg Oncol; 2010 Dec; 102(8):955-9. PubMed ID: 21165998
[TBL] [Abstract][Full Text] [Related]
5. Intraoperative sonography in patients with colorectal cancer and resectable liver metastases on preoperative FDG-PET-CT.
Wildi SM; Gubler C; Hany T; Petrowsky H; Clavien PA; Jochum W; Gerlach T; Fried M; Mullhaupt B
J Clin Ultrasound; 2008 Jan; 36(1):20-6. PubMed ID: 17937421
[TBL] [Abstract][Full Text] [Related]
6. Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT?
Ramos E; Valls C; Martinez L; Lladó L; Torras J; Ruiz S; Gamez C; Serrano T; Fabregat J; Rafecas A
Ann Surg Oncol; 2011 Sep; 18(9):2654-61. PubMed ID: 21431987
[TBL] [Abstract][Full Text] [Related]
7. FDG-PET improves management of patients with colorectal liver metastases allocated for local treatment: a consecutive prospective study.
Sørensen M; Mortensen FV; Høyer M; Vilstrup H; Keiding S;
Scand J Surg; 2007; 96(3):209-13. PubMed ID: 17966746
[TBL] [Abstract][Full Text] [Related]
8. Clinical impact of FDG PET-CT in patients with potentially operable metastatic colorectal cancer.
Briggs RH; Chowdhury FU; Lodge JP; Scarsbrook AF
Clin Radiol; 2011 Dec; 66(12):1167-74. PubMed ID: 21867996
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of
Shim JR; Lee SD; Han SS; Lee SJ; Lee DE; Kim SK; Kim SH; Park SJ; Oh JH
Eur J Surg Oncol; 2018 May; 44(5):670-676. PubMed ID: 29459018
[TBL] [Abstract][Full Text] [Related]
10. Comparison of multiphase CT, FDG-PET and intra-operative ultrasound in patients with colorectal liver metastases selected for surgery.
Wiering B; Ruers TJ; Krabbe PF; Dekker HM; Oyen WJ
Ann Surg Oncol; 2007 Feb; 14(2):818-26. PubMed ID: 17136470
[TBL] [Abstract][Full Text] [Related]
11. Improved long-term survival after resection of colorectal liver metastases following staging with FDG positron emission tomography.
Abbadi RA; Sadat U; Jah A; Praseedom RK; Jamieson NV; Cheow HK; Whitley S; Ford HE; Wilson CB; Harper SJ; Huguet EL
J Surg Oncol; 2014 Sep; 110(3):313-9. PubMed ID: 24737685
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography with F-18 fluorodeoxyglucose in evaluating colorectal hepatic metastasis down-staged by chemotherapy.
Takahashi S; Kuroki Y; Nasu K; Nawano S; Konishi M; Nakagohri T; Gotohda N; Saito N; Kinoshita T
Anticancer Res; 2006; 26(6C):4705-11. PubMed ID: 17214330
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET scanning correlates with tissue markers of poor prognosis and predicts mortality for patients after liver resection for colorectal metastases.
Riedl CC; Akhurst T; Larson S; Stanziale SF; Tuorto S; Bhargava A; Hricak H; Klimstra D; Fong Y
J Nucl Med; 2007 May; 48(5):771-5. PubMed ID: 17475966
[TBL] [Abstract][Full Text] [Related]
14. Improved selection of patients for hepatic surgery of colorectal liver metastases with (18)F-FDG PET: a randomized study.
Ruers TJ; Wiering B; van der Sijp JR; Roumen RM; de Jong KP; Comans EF; Pruim J; Dekker HM; Krabbe PF; Oyen WJ
J Nucl Med; 2009 Jul; 50(7):1036-41. PubMed ID: 19525451
[TBL] [Abstract][Full Text] [Related]
15. PET/CT: will it change the way that we use CT in cancer imaging?
Hicks RJ; Ware RE; Lau EW
Cancer Imaging; 2006 Oct; 6(Spec No A):S52-62. PubMed ID: 17114079
[TBL] [Abstract][Full Text] [Related]
16. Neither preoperative computed tomography nor intra-operative examination can predict metastatic lymph node in the hepatic pedicle in patients with colorectal liver metastasis.
Rau C; Blanc B; Ronot M; Dokmak S; Aussilhou B; Faivre S; Vilgrain V; Paradis V; Belghiti J
Ann Surg Oncol; 2012 Jan; 19(1):163-8. PubMed ID: 21837526
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET-CT is effective in selecting patients with poor long term survivals for colorectal liver metastases.
Yip VS; Poston GJ; Fenwick SW; Wieshmann H; Athwal T; Malik HZ
Eur J Surg Oncol; 2014 Aug; 40(8):995-9. PubMed ID: 24290370
[TBL] [Abstract][Full Text] [Related]
18. Controversies in the management of colorectal liver metastases: role of PET and PET/CT.
Wiering B; Vogel WV; Ruers TJ; Oyen WJ
Dig Surg; 2008; 25(6):413-20. PubMed ID: 19212113
[TBL] [Abstract][Full Text] [Related]
19. The role of 18FDG PET/CT in the management of colorectal liver metastases.
Engledow AH; Skipworth JR; Pakzad F; Imber C; Ell PJ; Groves AM
HPB (Oxford); 2012 Jan; 14(1):20-5. PubMed ID: 22151447
[TBL] [Abstract][Full Text] [Related]
20. Role of PET/CT in the detection of liver metastases from colorectal cancer.
Orlacchio A; Schillaci O; Fusco N; Broccoli P; Maurici M; Yamgoue M; Danieli R; D'Urso S; Simonetti G
Radiol Med; 2009 Jun; 114(4):571-85. PubMed ID: 19444590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
